S&P 500 7,686.14 â–ŧ 25.62 (-0.33%) DOW 53,185.90 â–ŧ 374.10 (-0.70%) NASDAQ 26,370.89 â–ŧ 31.53 (-0.12%) US Markets Closed â€ĸ 07:09 AM ET

ACON

Aclarion, Inc.

Price Chart

No historical data available

Latest Quote

$2.40

-0.12 (-4.76%)
Current Price
Previous Close $2.52
Open $2.52
Day High $2.52
Day Low $2.35
Volume 35,254
Fetched: 2026-08-31T05:58:48
Stock Information
Shares Outstanding 2.88M
Cash Equivalents $16.30M
Revenue $84K
Net Income $-9.20M
Sector Healthcare
Industry Health Information Services
Market Cap $6.92M
EPS (TTM) $-6.96
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Aclarion, Inc.

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

📰 Latest News
No news articles available at the moment. Check back later for updates on ACON.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $68,902 $84,658 $75,728 $65,298
Cost Of Revenue $68,902 $84,658 $75,728 $65,298
Total Revenue $75,730 $45,724 $75,404 $60,444
Operating Revenue $75,730 $45,724 $75,404 $60,444
Expenses
Interest Expense $0 $535,470 $608,288 $1,507,546
Total Expenses $7,128,121 $5,558,771 $4,952,529 $5,622,812
Other Income Expense $-592,299 $-944,728 $573,867 $-1,190
Other Non Operating Income Expenses $-4,752 $-49 $265 -
Net Non Operating Interest Income Expense $411,061 $-535,152 $-608,116 $-1,505,035
Interest Expense Non Operating $0 $535,470 $608,288 $1,507,546
Operating Expense $7,059,219 $5,474,113 $4,876,801 $5,557,514
Selling And Marketing Expense $1,900,598 $976,554 $757,004 $498,003
General And Administrative Expense $4,124,832 $3,608,793 $3,245,317 $3,990,719
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Net Interest Income $411,061 $-535,152 $-608,116 $-1,505,035
Interest Income $411,061 $318 $172 $2,511
Normalized Income $-6,646,082 $-6,048,248 $-5,484,976 $-7,067,403
Net Income From Continuing And Discontinued Operation $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Total Operating Income As Reported $-7,052,391 $-5,513,047 $-4,875,981 $-5,561,568
Net Income Common Stockholders $-7,240,312 $-7,052,602 $-4,911,374 $-7,484,116
Net Income $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Net Income Including Noncontrolling Interests $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Net Income Continuous Operations $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Pretax Income $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Special Income Charges $-599,353 $-1,279,712 $0 $0
Interest Income Non Operating $411,061 $318 $172 $2,511
Operating Income $-7,052,391 $-5,513,047 $-4,877,125 $-5,562,368
Gross Profit $6,828 $-38,934 $-324 $-4,854
Per Share
Diluted EPS $-13.61 $-5151.64 $-53971.14 $-138594.74
Basic EPS $-13.61 $-5151.64 $-53971.14 $-138594.74
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-6,418,676 $-5,319,640 $-4,714,017 $-5,416,236
Total Unusual Items $-587,547 $-944,679 $573,602 $-1,190
Total Unusual Items Excluding Goodwill $-587,547 $-944,679 $573,602 $-1,190
Reconciled Depreciation $227,406 $193,138 $162,671 $143,621
EBITDA (Bullshit earnings) $-7,006,223 $-6,264,319 $-4,140,415 $-5,417,426
EBIT $-7,233,629 $-6,457,457 $-4,303,086 $-5,561,047
Diluted Average Shares $532,036 $1,369 $91 $54
Basic Average Shares $532,036 $1,369 $91 $54
Diluted NI Availto Com Stockholders $-7,240,312 $-7,052,602 $-4,911,374 $-7,484,116
Preferred Stock Dividends $6,683 $59,675 - $415,523
Tax Provision $0 $0 $0 $0
Other Special Charges $599,353 $1,279,712 - -
Gain On Sale Of Security $11,806 $335,033 $573,602 $-1,190
Research And Development $1,033,789 $888,766 $873,336 $1,067,992
Selling General And Administration $6,025,430 $4,585,347 $4,002,321 $4,488,722
Other Gand A $4,124,832 $3,608,793 $3,245,317 $3,990,719
Other Taxes - $0 $1,144 $800
Fetched: 2026-08-25
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $11,583,586 $-323,648 $-1,896,618 $1,015,751
Total Assets $13,672,404 $2,123,483 $2,459,774 $2,914,629
Total Non Current Assets $1,275,700 $1,299,204 $1,170,405 $1,213,553
Goodwill And Other Intangible Assets $1,251,531 $1,293,705 $1,168,623 $1,210,207
Other Intangible Assets $1,251,531 $1,293,705 $1,168,623 $1,210,207
Current Assets $12,396,704 $824,279 $1,289,369 $1,701,076
Current Deferred Assets $0 $119,730 $100,588 $0
Restricted Cash $25,000 $10,000 $10,000 $10,000
Prepaid Assets $326,235 $183,560 $102,653 $150,053
Receivables $29,680 $18,326 $13,424 $18,653
Accounts Receivable $29,680 $18,326 $13,270 $18,569
Allowance For Doubtful Accounts Receivable $-6,241 $0 $0 $0
Gross Accounts Receivable $35,921 $18,326 $13,270 $18,569
Cash Cash Equivalents And Short Term Investments $12,015,789 $453,661 $1,021,069 $1,472,806
Cash And Cash Equivalents $12,015,789 $453,661 $1,021,069 $1,472,806
Other Current Assets - $158,732 $41,635 $49,564
Other Receivables - - $154 $84
Cash Financial - - $1,021,069 $1,472,806
Debt
Net Debt - - $104,655 -
Total Debt - - $1,125,724 -
Current Debt And Capital Lease Obligation - - $1,125,724 -
Current Debt - - $1,125,724 -
Liabilities
Total Liabilities Net Minority Interest $837,287 $1,153,426 $3,187,769 $688,671
Total Non Current Liabilities Net Minority Interest $0 $0 $0 $0
Current Liabilities $837,287 $1,153,426 $3,187,769 $688,671
Other Current Liabilities $63 $92,641 $443,788 $345,242
Payables And Accrued Expenses $377,613 $610,307 $1,263,177 $522,717
Payables $332,962 $531,603 $760,535 $462,202
Other Payable $8,492 $6,021 $1,714 $4,644
Accounts Payable $324,470 $525,582 $758,821 $457,558
Current Notes Payable - $0 $1,125,724 $0
Interest Payable - $0 $98,685 $0
Dividends Payable - - - $0
Equity
Common Stock Equity $12,835,117 $970,057 $-727,995 $2,225,958
Total Equity Gross Minority Interest $12,835,117 $970,057 $-727,995 $2,225,958
Stockholders Equity $12,835,117 $970,057 $-727,995 $2,225,958
Retained Earnings $-58,495,940 $-51,262,311 $-44,281,526 $-39,370,153
Preferred Stock Equity - - - -
Preferred Securities Outside Stock Equity - - - -
Other
Ordinary Shares Number $854,371 $1,369 $91 $54
Share Issued $854,371 $1,369 $91 $54
Tangible Book Value $11,583,586 $-323,648 $-1,896,618 $1,015,751
Invested Capital $12,835,117 $970,057 $397,729 $2,225,958
Working Capital $11,559,417 $-329,147 $-1,898,400 $1,012,405
Total Capitalization $12,835,117 $970,057 $-727,995 $2,225,958
Additional Paid In Capital $71,331,048 $52,232,368 $43,553,531 $41,596,106
Capital Stock $9 $0 $0 $5
Common Stock $9 $0 $0 $5
Preferred Stock $0 - $0 $0
Pensionand Other Post Retirement Benefit Plans Current $459,611 $450,478 $355,080 $165,954
Current Accrued Expenses $44,651 $78,704 $502,642 $60,515
Net PPE $24,169 $5,499 $1,782 $3,346
Accumulated Depreciation $-1,761 $-54,798 $-53,400 $-70,026
Gross PPE $25,930 $60,297 $55,182 $73,372
Machinery Furniture Equipment $25,930 $60,297 $55,182 $55,182
Treasury Shares Number - - $0 $0
Other Properties - - - $18,190
Line Of Credit - - - -
Fetched: 2026-08-25
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-7,368,106 $-5,593,546 $-3,766,469 $-5,157,982
Operating Activities
Operating Cash Flow $-7,164,204 $-5,271,609 $-3,646,947 $-4,949,112
Cash Flow From Continuing Operating Activities $-7,164,204 $-5,271,610 $-3,646,946 $-4,949,113
Operating Gains Losses $-11,806 $-223,105 $-573,457 $3,789
Investing Activities
Capital Expenditure $-203,902 $-321,937 $-119,522 $-208,870
Investing Cash Flow $-203,902 $-321,937 $-119,522 $-207,870
Cash Flow From Continuing Investing Activities $-203,902 $-321,937 $-119,522 $-207,870
Net Other Investing Changes - - - $1,000
Financing Activities
Repurchase Of Capital Stock $-1,213,590 $0 $-1,000 $0
Issuance Of Capital Stock $20,257,513 $6,573,075 $1,463,949 $8,552,318
Financing Cash Flow $18,945,234 $5,026,138 $3,314,732 $6,187,258
Cash Flow From Continuing Financing Activities $18,945,234 $5,026,138 $3,314,732 $6,187,258
Net Other Financing Charges $-2,408,087 $-1,245,964 $-398,217 $-365,060
Net Preferred Stock Issuance $-1,213,590 $1,000,000 $0 $0
Preferred Stock Issuance $0 $1,000,000 $1,000 $0
Net Common Stock Issuance $20,257,513 $5,573,075 $1,462,949 $8,552,318
Common Stock Issuance $20,257,513 $5,573,075 $1,462,949 $8,552,318
Other
Repayment Of Debt $0 $-300,973 $0 $-2,000,000
Interest Paid Supplemental Data $0 $13,072 $10,705 -
Income Tax Paid Supplemental Data $1,691 $0 $0 -
End Cash Position $12,040,789 $463,661 $1,031,069 $1,482,806
Beginning Cash Position $463,661 $1,031,069 $1,482,806 $452,530
Changes In Cash $11,577,128 $-567,408 $-451,737 $1,030,276
Proceeds From Stock Option Exercised $2,309,398 $0 $0 $8,552,318
Preferred Stock Payments $-1,213,590 $0 $-1,000 $0
Net Issuance Payments Of Debt $0 $-300,973 $2,250,000 $-2,000,000
Net Long Term Debt Issuance $0 $-300,973 $2,250,000 $-2,000,000
Long Term Debt Payments $0 $-300,973 $0 $-2,000,000
Net Intangibles Purchase And Sale $-182,374 $-316,822 $-119,522 $-208,870
Net PPE Purchase And Sale $-21,528 $-5,115 $0 $1,000
Change In Working Capital $-357,902 $-564,244 $622,872 $-616,095
Change In Payables And Accrued Expense $-362,605 $-283,852 $662,902 $-516,283
Change In Accrued Expense $-163,964 $-127,449 $442,269 $86,819
Change In Payable $-198,641 $-156,403 $220,633 $-603,102
Change In Account Payable $-198,641 $-156,403 $220,633 $-603,102
Change In Prepaid Assets $16,057 $-287,663 $-38,539 $-87,522
Change In Receivables $-11,354 $7,271 $-1,491 $-12,290
Changes In Account Receivables $-11,354 $7,271 $-1,491 $-12,290
Other Non Cash Items $106,359 $2,028,074 $596,340 $1,299,508
Stock Based Compensation $105,368 $287,455 $456,001 $1,288,658
Depreciation Amortization Depletion $227,406 $193,138 $162,671 $143,621
Depreciation And Amortization $227,406 $193,138 $162,671 $143,621
Amortization Cash Flow $224,548 $191,739 $161,107 $139,121
Amortization Of Intangibles $224,548 $191,739 $161,107 $139,121
Depreciation $2,858 $1,399 $1,564 $4,500
Gain Loss On Investment Securities $-11,806 $-335,033 $-573,457 -
Net Income From Continuing Operations $-7,233,629 $-6,992,927 $-4,911,374 $-7,068,593
Issuance Of Debt - $0 $2,250,000 $0
Long Term Debt Issuance - $0 $2,250,000 $0
Change In Interest Payable - $0 $-6,190 $200,712
Net Short Term Debt Issuance - - $2,250,000 $0
Short Term Debt Payments - - $0 $-2,000,000
Short Term Debt Issuance - - $2,250,000 $0
Purchase Of Intangibles - - $-119,522 $-208,870
Sale Of PPE - - $0 $1,000
Gain Loss On Sale Of PPE - - $0 $3,789
Purchase Of PPE - - - -
Fetched: 2026-08-25